Mouse Model for NRAS-Induced Leukemogenesis

Methods in Enzymology

Volumn 439, Issue , 2008, Pages 15-24

  Parikh, Chaitali ^a   Ren, Ruibao ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW TRANSPLANTATION; CANCER CELL CULTURE; GENE MUTATION; GENETIC TRANSFECTION; LEUKEMOGENESIS; MOLECULAR BIOLOGY; MOUSE; MYELOID LEUKEMIA; NONHUMAN; NRAS GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ANIMAL; ARTICLE; CELL STRAIN 3T3; DISEASE MODEL; GENETICS; ONCOGENE RAS; PHYSIOLOGY; RETROVIRUS;

ANIMALIA; MURINAE;

ANIMALS; DISEASE MODELS, ANIMAL; GENES, RAS; LEUKEMIA, MYELOID; MICE; NIH 3T3 CELLS; RETROVIRIDAE;

EID: 45549083509     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)00402-8     Document Type: Review

References (20)

1. Bos J.L. Ras oncogenes in hematopoietic malignancies. Hematol. Pathol. 2 (1988) 55-63
2. Bos J.L. Ras oncogenes in human cancer: A review. Cancer Res. 49 (1989) 4682-4689
3. Braun B.S., Tuveson D.A., Kong N., Le D.T., Kogan S.C., Rozmus J., Le Beau M.M., Jacks T.E., and Shannon K.M. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc. Natl. Acad. Sci. USA 101 (2004) 597-602
4. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., and Der C.J. Increasing complexity of Ras signaling. Oncogene 17 (1998) 1395-1413
5. Challita P.M., and Kohn D.B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91 (1994) 2567-2571
6. Chan I.T., Kutok J.L., Williams I.R., Cohen S., Kelly L., Shigematsu H., Johnson L., Akashi K., Tuveson D.A., Jacks T., and Gilliland D.G. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J. Clin. Invest. 113 (2004) 528-538
7. Halene S., Wang L., Cooper R.M., Bockstoce D.C., Robbins P.B., and Kohn D.B. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood 94 (1999) 3349-3357
8. Hancock J.F. Ras proteins: Different signals from different locations. Nat. Rev. MolCell Biol. 4 (2003) 373-384
9. Haupt Y., Harris A.W., and Adams J.M. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc. Oncogene 7 (1992) 981-986
10. Hawley R.G., Fong A.Z., Ngan B.Y., and Hawley T.S. Hematopoietic transforming potential of activated ras in chimeric mice. Oncogene 11 (1995) 1113-1123
11. Kogan S.C., Lagasse E., Atwater S., Bae S.C., Weissman I., Ito Y., and Bishop J.M. The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. Proc. Natl. Acad. Sci. USA 95 (1998) 11863-11868
12. Kogan S.C., Ward J.M., Anver M.R., Berman J.J., Brayton C., Cardiff R.D., Carter J.S., de Coronado S., Downing J.R., Fredrickson T.N., Haines D.C., Harris A.W., et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100 (2002) 238-245
13. Longley D.B., Harkin D.P., and Johnston P.G. 5-Fluorouracil: Mechanisms of action and clinical strategies. Nat. Rev. Cancer 3 (2003) 330-338
14. MacKenzie K.L., Dolnikov A., Millington M., Shounan Y., and Symonds G. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice. Blood 93 (1999) 2043-2056
15. Parikh C., Subrahmanyam R., and Ren R. Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice. Blood 108 (2006) 2349-2357
16. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90 (1993) 8392-8396
17. Reuter C.W., Morgan M.A., and Bergmann L. Targeting the Ras signaling pathway: A rational, mechanism-based treatment for hematologic malignancies?. Blood 96 (2000) 1655-1669
18. Shields J.M., Pruitt K., McFall A., Shaub A., and Der C.J. Understanding Ras: 'it ain't over 'til it's over.'. Trends Cell Biol. 10 (2000) 147-154
19. Sinn E., Muller W., Pattengale P., Tepler I., Wallace R., and Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell 49 (1987) 465-475
20. Warner J.K., Wang J.C., Hope K.J., Jin L., and Dick J.E. Concepts of human leukemic development. Oncogene 23 (2004) 7164-7177